NeuroSense Therapeutics L...

NASDAQ: NRSNW · Real-Time Price · USD
0.38
-0.06 (-13.44%)
At close: Jun 06, 2025, 12:14 PM
0.38
0.00%
After-hours: Jun 06, 2025, 04:00 PM EDT

NeuroSense Therapeutics Statistics

Share Statistics

NeuroSense Therapeutics has 23.99M shares outstanding. The number of shares has increased by null% in one year.

23.99M
n/a
n/a
0.59%
n/a
779
9.6%

Short Selling Information

The latest short interest is 4.4K, so 0% of the outstanding shares have been sold short.

4.4K
n/a
n/a
2.77

Valuation Ratios

The PE ratio is -2.19 and the forward PE ratio is null. NeuroSense Therapeutics's PEG ratio is 0.06.

-2.19
n/a
0
9.8
8.64
-2.2
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NeuroSense Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.03.

2.21
2.21
0.03
-0.01
-0.01
-31.84

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-600,588.24
17
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 137.84% in the last 52 weeks. The beta is 1.6, so NeuroSense Therapeutics's price volatility has been higher than the market average.

1.6
137.84%
0.26
0.25
61.73
8,113

Income Statement

n/a
-22K
-9.9M
-10.21M
-9.88M
-9.9M
-0.55
Full Income Statement

Balance Sheet

The company has 3.38M in cash and 73K in debt, giving a net cash position of 3.31M.

3.38M
73K
3.31M
-36.66M
n/a
n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.13M and capital expenditures -3K, giving a free cash flow of -10.14M.

-10.13M
-3K
-10.14M
-0.54
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

NRSNW does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NRSNW.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

n/a
n/a